Mednet Logo
Community

What is the current opinion on G-CSF usage for AML patients during induction and consolidation phases of treatment?

It used to be a contraindication for G-CSF use for AML patients, but currently, several protocols include it to decrease neutropenic duration.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Baylor College of Medicine
Answered on

I agree with you that the use of G-CSF for AML patients is still controversial. There are two reasons for using G-CSF for patients with AML. One is to sensitize, or “prime,” the leukemia by driving quiescent blasts into cell cycle and by mobilizing blasts out of their protective niches and into the ...

Join for free or sign in to see the full answer